WASHINGTON, DC – SEPTEMBER 21, 2010 – A new drug-eluting stent design demonstrated superiority over a traditional drug-eluting stent at 6 months, according to a study led by Laura Mauri, MD, Associate ...

In the quest for increasingly thinner, smaller, and more-flexible stents, medical device designers may have compromised structural integrity in some current-generation drug-eluting stents (DES). And ...

As understanding of the mechanisms of restenosis evolves, so too does drug-eluting stent (DES) technology. Given the various components, including a bare-metal stent, carrier coating, bioactive drug, ...

The latest and largest trial to compare durable-polymer versus biodegradable-polymer stents—this time in the setting of acute coronary syndromes—should convince the field once and for all that a ...

Biodegradable polymers represent the future of stent design, according to Yaling Han, director of the department of cardiology at Shenyang Northern Hospital (China). Han's hypothesis follows her ...

November 24, 2011 (Rockville, Maryland and Detroit, Michigan) — The US Food and Drug Administration (FDA) has approved the Promus Element Plus everolimus-eluting chromium platinum coronary stent ...

SUPERB Trial and SUPERA 500 Registry Both Demonstrate Highest Reported Patency Rates and Zero Fracture Rates Data Presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) ...

How a wireless stent can be used for an implanted sensor and inductive link. How the wireless stent was fabricated and used. How the stent’s performance was evaluated. There are multiple options for ...

Suncica "Sunny" Canic was good at math in school, so that's what she pursued as a career. But she always liked medicine, too. When she moved to Houston, Texas, and met some cardiologists at a party, ...

When someone comes in for a new heart stent, it's critical that the medical team doing the procedure knows several key facts about previous stents the patient has had. But fewer than half of patients ...

Many patients with heart disease have a metal stent implanted to keep their coronary artery open, preventing blood clots that can lead to heart attacks. One drawback to these stents is that long-term ...

Over $8 billion worth of coronary stents will be sold annually by 2025, according to a new research report by Global Market Insights, Inc. The increase over the years will be created by an increase in ...